Cancer Diagnostics Market by Methods (Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy) for Blood Cancer, Breast Cancer, Colorectal Cancer (CRC), Lung Cancer, Other: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 – 2020
The report covers forecast and analysis for the cancer diagnostics market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Billion). The study includes drivers and restraints for the cancer diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer diagnostics market on a global level.
Global Cancer Diagnostics Market 2014 – 2020
In order to give the users of this report a comprehensive view on the cancer diagnostics. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the cancer diagnostics market has also been included. The study encompasses a market attractiveness analysis, wherein methods segments and application segments are benchmarked based on their market size, growth rate and general attractiveness.
The study provides a decisive view on the cancer diagnostics market by segmenting the market based on methods of diagnostics, applications and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. Based on methods the market is segmented into tumor biomarker tests, imaging, endoscopy, and biopsy. Key application market covered under this study includes blood cancer, breast cancer, colorectal cancer (CRC), kidney cancer, liver cancer, lung cancer, ovarian cancer, pancreatic cancer, and prostate cancer. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for cancer diagnostics based on individual applications in all the regions and countries.
The report also includes detailed profiles of end players such as Abbott Laboratories, Inc., Ambry Genetics, AstraZeneca plc, bioMeriux SA, Eli Lilly and Company, Genoptix, Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Pfizer, Inc. The detailed description of players includes parameters such as company overview, financial overview, business and recent developments of the company.
This report segments the global cancer diagnostics market as follows:
Global Cancer Diagnostics Market: Methods Segment Analysis
- Tumor Biomarker Tests
Global Cancer Diagnostics Market: Application Segment Analysis
Browse detail report at: http://atozresearch.com/global-cancer-diagnostics-market-industry-perspective-analysis-size-share-growth/
- Blood Cancer
- Breast Cancer
- Colorectal Cancer (CRC)
- Lung Cancer
Global Cancer Diagnostics Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Read Report TOC: http://bit.ly/2faf6Dw